Key statistics
As of last trade, Amylyx Pharmaceuticals Inc (AMLX:NSQ) traded at 5.34, 238.73% above the 52 week low of 1.58 set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.33 |
---|---|
High | 5.39 |
Low | 5.15 |
Bid | 5.33 |
Offer | 5.34 |
Previous close | 5.19 |
Average volume | 1.97m |
---|---|
Shares outstanding | 68.55m |
Free float | 54.27m |
P/E (TTM) | -- |
Market cap | 355.76m USD |
EPS (TTM) | -3.82 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:28 GMT.
More ▼
- Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
- Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
- Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
- Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024
- Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
More ▼